BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30426724)

  • 1. Serum from Asthmatic Mice Potentiates the Therapeutic Effects of Mesenchymal Stromal Cells in Experimental Allergic Asthma.
    Abreu SC; Xisto DG; de Oliveira TB; Blanco NG; de Castro LL; Kitoko JZ; Olsen PC; Lopes-Pacheco M; Morales MM; Weiss DJ; Rocco PRM
    Stem Cells Transl Med; 2019 Mar; 8(3):301-312. PubMed ID: 30426724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma.
    Abreu SC; Lopes-Pacheco M; da Silva AL; Xisto DG; de Oliveira TB; Kitoko JZ; de Castro LL; Amorim NR; Martins V; Silva LHA; Gonçalves-de-Albuquerque CF; de Castro Faria-Neto HC; Olsen PC; Weiss DJ; Morales MM; Diaz BL; Rocco PRM
    Front Immunol; 2018; 9():1147. PubMed ID: 29881388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum from patients with asthma potentiates macrophage phagocytosis and human mesenchymal stromal cell therapy in experimental allergic asthma.
    Abreu S; Alves L; Carvalho L; Xisto D; Blanco N; Castro L; Olsen P; Lapa E Silva JR; Morales MM; Lopes-Pacheco M; Weiss D; Rocco PRM
    Cytotherapy; 2023 Sep; 25(9):967-976. PubMed ID: 37330732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow, Adipose, and Lung Tissue-Derived Murine Mesenchymal Stromal Cells Release Different Mediators and Differentially Affect Airway and Lung Parenchyma in Experimental Asthma.
    Abreu SC; Antunes MA; Xisto DG; Cruz FF; Branco VC; Bandeira E; Zola Kitoko J; de Araújo AF; Dellatorre-Texeira L; Olsen PC; Weiss DJ; Diaz BL; Morales MM; Rocco PRM
    Stem Cells Transl Med; 2017 Jun; 6(6):1557-1567. PubMed ID: 28425576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic administration of bone marrow-derived mesenchymal stromal cells reduces airway inflammation without up-regulating Tregs in experimental asthma.
    Kitoko JZ; de Castro LL; Nascimento AP; Abreu SC; Cruz FF; Arantes AC; Xisto DG; Martins MA; Morales MM; Rocco PRM; Olsen PC
    Clin Exp Allergy; 2018 Feb; 48(2):205-216. PubMed ID: 29068567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoleamine 2,3-Dioxygenase Is Not a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation through Adipose-Derived Stem Cells.
    Cho KS; Park MK; Mun SJ; Park HY; Yu HS; Roh HJ
    PLoS One; 2016; 11(11):e0165661. PubMed ID: 27812173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model.
    Urbanek K; De Angelis A; Spaziano G; Piegari E; Matteis M; Cappetta D; Esposito G; Russo R; Tartaglione G; De Palma R; Rossi F; D'Agostino B
    PLoS One; 2016; 11(7):e0158746. PubMed ID: 27434719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human adipose tissue mesenchymal stromal cells and their extracellular vesicles act differentially on lung mechanics and inflammation in experimental allergic asthma.
    de Castro LL; Xisto DG; Kitoko JZ; Cruz FF; Olsen PC; Redondo PAG; Ferreira TPT; Weiss DJ; Martins MA; Morales MM; Rocco PRM
    Stem Cell Res Ther; 2017 Jun; 8(1):151. PubMed ID: 28646903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung Tissue Damage Associated with Allergic Asthma in BALB/c Mice Could Be Controlled with a Single Injection of Mesenchymal Stem Cells from Human Bone Marrow up to 14 d After Transplantation.
    Boldrini-Leite LM; Michelotto PV; de Moura SAB; Capriglione LGA; Barussi FCM; Fragoso FYI; Senegaglia AC; Brofman PRS
    Cell Transplant; 2020; 29():963689720913254. PubMed ID: 32216447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPO modified MSCs can inhibit asthmatic airway remodeling in an animal model.
    Han XP; Zhang FQ; Tan XS; Liu L; Ma WX; Ou-Yang HF; Wu CG
    J Cell Biochem; 2018 Jan; 119(1):1008-1016. PubMed ID: 28686347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regular and moderate aerobic training before allergic asthma induction reduces lung inflammation and remodeling.
    de Araújo CC; Marques PS; Silva JD; Samary CS; da Silva AL; Henriques I; Antunes MA; de Oliveira MV; Goldenberg RC; Morales MM; Abreu I; Diaz BL; Rocha NN; Capelozzi VL; Rocco PR
    Scand J Med Sci Sports; 2016 Nov; 26(11):1360-1372. PubMed ID: 27152850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation of airway epithelium cell activation by mesenchymal stromal cells ameliorates house dust mite-induced airway inflammation in mice.
    Duong KM; Arikkatt J; Ullah MA; Lynch JP; Zhang V; Atkinson K; Sly PD; Phipps S
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):615-24. PubMed ID: 25789608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
    Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
    Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple doses of adipose tissue-derived mesenchymal stromal cells induce immunosuppression in experimental asthma.
    Castro LL; Kitoko JZ; Xisto DG; Olsen PC; Guedes HLM; Morales MM; Lopes-Pacheco M; Cruz FF; Rocco PRM
    Stem Cells Transl Med; 2020 Feb; 9(2):250-260. PubMed ID: 31746562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of human mesenchymal stem cells on airway inflammation in allergic asthma mice and the underlying mechanism].
    Ren NN; Chen HJ; Chen QL; Eileen J; An YG; Lin Y
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2697-2702. PubMed ID: 28910960
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice.
    Dong L; Wang Y; Zheng T; Pu Y; Ma Y; Qi X; Zhang W; Xue F; Shan Z; Liu J; Wang X; Mao C
    Stem Cell Res Ther; 2021 Jan; 12(1):4. PubMed ID: 33407872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells.
    Ou-Yang HF; Huang Y; Hu XB; Wu CG
    Exp Biol Med (Maywood); 2011 Dec; 236(12):1461-7. PubMed ID: 22114062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice.
    Sun YQ; Deng MX; He J; Zeng QX; Wen W; Wong DS; Tse HF; Xu G; Lian Q; Shi J; Fu QL
    Stem Cells; 2012 Dec; 30(12):2692-9. PubMed ID: 22987325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratracheal transplantation of bone marrow-derived mesenchymal stem cells reduced airway inflammation and up-regulated CD4⁺CD25⁺ regulatory T cells in asthmatic mouse.
    Ge X; Bai C; Yang J; Lou G; Li Q; Chen R
    Cell Biol Int; 2013 Jul; 37(7):675-86. PubMed ID: 23483727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhaled inactivated Mycobacterium phlei on airway inflammation in mouse asthmatic models.
    Zhang J; Li C; Guo S
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):96-103. PubMed ID: 22149063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.